RO-634

N/A

Report date: 2025/01/26 16:30:29

Base Information

Drug NameRO-634
Drug Alias NameAnti-VEGF-A/Ang-2 bispecific surrobody (University of Colorado Anschutz Medical Campus)RO-634
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAngiopoietin-2 modulatorsVascular endothelial growth factor A modulators
TargetsAngiopoietin-2Vascular endothelial growth factor A
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Colorado Anschutz Medical Campus
China Registration ClassN/A

Develop Information

Active CompaniesCleveland Clinic Cole Eye InstituteSpringfield Clinic LLPUniversity of Colorado Anschutz Medical Campus
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A